Congo Begins Ebola Vaccine Trials as EU Sends Expert Help

A major international response is bringing new hope to communities affected by an Ebola outbreak in the Democratic Republic of Congo.

The World Health Organization announced that 20,000 doses of the Ervebo vaccine have arrived in Ituri province, where health workers and frontline personnel are beginning a research vaccination program. The vaccine has proven highly effective against one strain of Ebola in the past, and scientists are now testing whether it can protect against the Bundibugyo virus driving the current outbreak.

This marks a significant step forward because no licensed vaccine or treatment currently exists for this particular Ebola strain. An additional 50,000 doses are available to support the broader outbreak response and related research, bringing the total to 70,000 doses allocated to Congolese health authorities.

Meanwhile, the European Centre for Disease Prevention and Control is deploying two epidemiologists directly to the outbreak's epicenter. The experts will strengthen surveillance systems and support the overall response effort, joining a coordinated international team that has been working alongside the Africa CDC since May.

The ECDC has already conducted airport exit screenings in the DRC and Uganda and deployed specialists to neighboring South Sudan. This multi-country coordination aims to prevent the virus from spreading beyond affected regions while caring for those already sick.

The Ripple Effect

The international community's swift response demonstrates how global health partnerships can mobilize resources when they're needed most. By protecting healthcare workers first through vaccination trials, the effort creates a safer environment for everyone seeking medical care in affected areas.

The collaboration between African and European health agencies, the WHO, and local authorities shows what's possible when nations work together on urgent health challenges. Each vaccinated healthcare worker can continue serving their community safely, and every trained epidemiologist strengthens the region's capacity to track and contain the outbreak.

European health officials confirm the risk to people outside Africa remains very low, even as they continue supporting affected communities.

This coordinated response brings both immediate protection and long-term knowledge that could save countless lives in future outbreaks.